Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RETT Syndrome With Proven MECP2 Mutation”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Looking for participantsNCT07430046
What this trial is testing

Repurposing Mirtazapine in Rett Syndrome

Who this might be right for
RETT Syndrome With Proven MECP2 Mutation
University of Trieste 54
Not applicableStudy completedNCT02110797
What this trial is testing

Osteoporosis in RETT Syndrome

Who this might be right for
RETT Syndrome With Proven MECP2 Mutation
Assistance Publique - Hôpitaux de Paris 98
Not applicableLooking for participantsNCT07493096
What this trial is testing

Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders

Who this might be right for
Neurodevelopmental DisordersNeurodevelopmental Disorders (NDD)Neurodevelopmental Disorders and Developmental Abnormalities+20 more
Healing Hope International 100
Not applicableEnrolling By InvitationNCT06739434
What this trial is testing

GCB-002 in Treatment of Patients With Rett Syndrome

Who this might be right for
RETT Syndrome With Proven MECP2 Mutation
Genecombio Ltd. 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07257978
What this trial is testing

Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

Who this might be right for
RETT Syndrome With Proven MECP2 MutationRett Syndrome
Fenix Innovation Group 40